The use of intramuscular glucagon to prevent IV glucose infusion in early neonatal hypoglycemia.

Yair KasirerOphir DotanFrancis B MimouniNetanel WasserteilCathy Hammerman Alona Bin Nun

Published in: Journal of perinatology : official journal of the California Perinatal Association (2021)

Glucagon increases BG nearly universally in hypoglycemic infants and allowed reducing the number of infants that needed immediate IV glucose infusion therapy by ≈half.

Keyphrases

low dose
blood glucose
type diabetes
stem cells
metabolic syndrome
mesenchymal stem cells
bone marrow
insulin resistance